Prokineticin 1 receptor antagonists
Abstract:
The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 1 or prokinetin 1 receptor mediated disorders.
Public/Granted literature
Information query
Patent Agency Ranking
0/0